Dr. Dansey, Seagen’s Chief Medical Officer, brings extensive expertise in immuno-oncology and drug development Appointment of industry leader in drug development expands the Board’s diverse industry, clinical development, research and commercialization expertise
May 17, 2021
· 8 min read